Literature DB >> 2426478

Analysis of fixation effects on immunohistochemical localization of prostatic specific antigen in human prostate.

A A Sinha, K A Hagen, R K Sibley, M J Wilson, C Limas, P K Reddy, C E Blackard, D F Gleason.   

Abstract

We studied human prostatic specific antigen (PSA) localization in human prostate to investigate the possibility that the previously reported variations in the intensity of antigen staining were due to fixation and embedding methods. We have evaluated the effects of physical and several chemical fixatives on prostate samples obtained immediately after prostatectomies and radical cystectomies. Our analysis of fixation effects and immunohistochemical staining of polyclonal antibody to PSA indicates that the formalin fixation and paraffin embedding methods used previously did provide optimum localization of the antigen and the variations in the intensity of PSA staining could not be attributed to the methodology. Although PSA staining was relatively uniform in the lower grade neoplastic tumors, the higher grade, moderately to poorly differentiated tumors showed intense-through-weak PSA localization or no PSA staining suggesting that PSA staining intensity was not uniformly related to tumor differentiation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426478     DOI: 10.1016/s0022-5347(17)45036-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.

Authors:  M P Gallee; E Visser-de Jong; J A van der Korput; T H van der Kwast; F J ten Kate; F H Schroeder; J Trapman
Journal:  Urol Res       Date:  1990

2.  Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor.

Authors:  Mathilda Eriksson; Kalle Andreasson; Joachim Weidmann; Kajsa Lundberg; Karin Tegerstedt; Tina Dalianis; Torbjörn Ramqvist
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.